Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK

被引:0
|
作者
Modar Khalil
Hassan W Zafar
Victoria Quarshie
Fayyaz Ahmed
机构
[1] Hull Royal Infirmary,Specialist Registrar in Neurology
[2] Hull Royal Infirmary,Specialist Headache Nurse
[3] Consultant Neurologist,undefined
[4] Hull Royal Infirmary,undefined
来源
关键词
Migraine; National Health Service; Chronic Migraine; Medication Overuse; Episodic Migraine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
    Khalil, Modar
    Zafar, Hassan W.
    Quarshie, Victoria
    Ahmed, Fayyaz
    [J]. JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [2] Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
    Khalil, M.
    Zafar, H.
    Quarshie, V.
    Ahmed, F.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [3] Prospective analysis of the use of onabotulinumtoxina (Botox) in the treatment of chronic migraine; real-life data in 419 patients from hull, UK: an update!
    Khalil, M.
    Zafar, H.
    Quarshie, V.
    Ahmed, F.
    [J]. CEPHALALGIA, 2015, 35 : 36 - 37
  • [4] EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
    M Khalil
    H Zafar
    V Quarshie
    F Ahmed
    [J]. The Journal of Headache and Pain, 2014, 15
  • [5] Hull Prospective Analysis of OnabotulinumtoxinA (Botox) in the treatment of Chronic Migraine; a real-life data in 742 patients; updated results on over six years of experience
    Ahmed, Fayyaz
    Ghabeli, Ali J.
    Buture, Alina
    Khalil, Modar
    [J]. CEPHALALGIA, 2017, 37 : 112 - 112
  • [6] Hull Prospective Analysis of OnabotulinumtoxinA (Botox)® in the treatment of chronic migraine; real-life data in 1306 patients; updated results on over 12 years experience
    Khan, Rafiullah
    Khalil, Modar
    Buture, Alina
    Ahmed, Fayyaz
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 268 - 269
  • [7] Hull Prospective Analysis of OnabotulinumtoxinA (Botox) in the treatment of Chronic Migraine; a real-life data in 972 patients; updated results on over 8 years of experience
    Ahmed, Fayyaz
    Buture, Alina
    Tanvir, Taukir
    Khalil, Modar
    [J]. CEPHALALGIA, 2019, 39 : 276 - 277
  • [8] HULL PROSPECTIVE ANALYSIS OF ONABOTULINUMTOXINA (BOTOX) IN THE TREATMENT OF CHRONIC MIGRAINE; A REAL-LIFE DATA IN 796 PATIENTS; UPDATED RESULTS ON OVER SEVEN YEARS OF EXPERIENCE
    Ahmed, F.
    Khalil, M.
    Tanvir, T.
    Buture, A.
    [J]. CEPHALALGIA, 2018, 38 : 85 - 85
  • [9] HULL PROSPECTIVE ANALYSIS OF ONABOTULINUMTOXINA IN THE TREATMENT OF CHRONIC MIGRAINE; REAL LIFE DATA IN 536 PATIENTS; AN UPDATE
    Ahmed, F.
    Khalil, M.
    Buture, A.
    Nimeri, R.
    [J]. CEPHALALGIA, 2016, 36 : 11 - 12
  • [10] 10 Year follow up on 337 patients receiving OnabotulinumtoxinA (Botox) for Chronic Migraine, data from the Hull (UK) Migraine Clinic
    Khan, Rafiullah
    Delrosario, Helen
    Khalil, Modar
    Dorsey, Sophie
    Ijaz, Aamir
    Ahmed, Fayyaz
    [J]. CEPHALALGIA, 2023, 43 (1supp)